Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Retisert in Refractory Ocular Behcet's Disease
NCT00720928Phase 4Unknown
- Sponsor
- Asan Medical Center
- Start
- Jul 2008
- Primary completion
- Dec 2009
- Countries
- 1
01
Overview
A Phase 4 trial of fluocinolone in Behcet disease, noninfectious uveitis (NIU), uveitis, sponsored by Asan Medical Center. Status: unknown.
02
Drugs
fluocinolone
03
Conditions
Behcet diseasenoninfectious uveitis (NIU)uveitis
Beyond the preview
Go deeper on NCT00720928.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00720928.